An assessment of the external validity of mapping QLQ-C30 to EQ-5D preferences
Author:
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Link
http://link.springer.com/content/pdf/10.1007/s11136-012-0220-9.pdf
Reference28 articles.
1. Crott, R., & Briggs, A. (2010). Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences. European Journal of Health Economics, 11(4), 427–434.
2. Therasse, P., Mauriac, L., Welnicka-Jaskiewicz, M., Bruning, P., Cufer, T., Bonnefoi, H., et al. (2003). Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose- intensified epirubicin and cyclophosphamide_filgrastim as neoadjuvant treatment in locally advanced breast cancer: An EORTC-NCIC-SAKK multicenter study. Journal of Clinical Oncology, 21(5), 843–850.
3. Lokhorst, H. M., Segeren, C. M., Verdonck, L. F., van der Holt, B., Raymakers, R., van Oers, M. H., et al. (2003). Dutch-Belgian hemato-oncology cooperative group. Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MM. Journal of Clinical Oncology, 21(9), 1728–1733.
4. Doorduijn, J. K., van der Holt, B., van Imhoff, G. W., van der Hem, K. G., Kramer, M. H., van Oers, M. H., et al. (2003). CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin’s lymphoma. Journal of Clinical Oncology, 21(16), 3041–3050.
5. Versteegh, M. M., Leunis, A., Luime, J. J., Boggild, M., Uyl-de Groot, C. A. & Stolk, E. A., et al. (2011). Mapping QLQ-C30, HAQ and MSIS-29 on EQ-5D, Medical Decision Making (published online November 22, 2011).
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A systematic review of health state utility values for older people with acute myeloid leukaemia;Quality of Life Research;2024-08-22
2. Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost–utility analysis alongside a randomized HYPO-RT-PC trial;The European Journal of Health Economics;2022-05-19
3. Health-Related Quality of Life Data in Cancer Clinical Trials for Drug Registration: The Value Beyond Reimbursement;JCO Clinical Cancer Informatics;2021-01
4. Health-related quality of life measured using EQ-5D in patients with lymphomas;Supportive Care in Cancer;2020-09-19
5. EQ-5D–Derived Health State Utility Values in Hematologic Malignancies: A Catalog of 796 Utilities Based on a Systematic Review;Value in Health;2020-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3